Dian Diagnostics GroupLtd Balance Sheet Health
Financial Health criteria checks 5/6
Dian Diagnostics GroupLtd has a total shareholder equity of CN¥9.8B and total debt of CN¥3.7B, which brings its debt-to-equity ratio to 38.1%. Its total assets and total liabilities are CN¥17.5B and CN¥7.7B respectively. Dian Diagnostics GroupLtd's EBIT is CN¥584.0M making its interest coverage ratio 2. It has cash and short-term investments of CN¥2.2B.
Key information
38.1%
Debt to equity ratio
CN¥3.75b
Debt
| Interest coverage ratio | 2x |
| Cash | CN¥2.18b |
| Equity | CN¥9.83b |
| Total liabilities | CN¥7.71b |
| Total assets | CN¥17.55b |
Recent financial health updates
Recent updates
Dian Diagnostics Group Co.,Ltd.'s (SZSE:300244) Shares Bounce 37% But Its Business Still Trails The Industry
Oct 04
Dian Diagnostics Group Co.,Ltd. (SZSE:300244) Looks Inexpensive But Perhaps Not Attractive Enough
Aug 20Returns On Capital Signal Tricky Times Ahead For Dian Diagnostics GroupLtd (SZSE:300244)
Jul 12Dian Diagnostics GroupLtd (SZSE:300244) Will Pay A Smaller Dividend Than Last Year
Jun 10Dian Diagnostics GroupLtd (SZSE:300244) Seems To Use Debt Quite Sensibly
May 24Dian Diagnostics Group Co.,Ltd. Just Missed Earnings - But Analysts Have Updated Their Models
Apr 30Investors Holding Back On Dian Diagnostics Group Co.,Ltd. (SZSE:300244)
Apr 22Financial Position Analysis
Short Term Liabilities: 300244's short term assets (CN¥13.2B) exceed its short term liabilities (CN¥5.0B).
Long Term Liabilities: 300244's short term assets (CN¥13.2B) exceed its long term liabilities (CN¥2.7B).
Debt to Equity History and Analysis
Debt Level: 300244's net debt to equity ratio (16%) is considered satisfactory.
Reducing Debt: 300244's debt to equity ratio has reduced from 75.7% to 38.1% over the past 5 years.
Debt Coverage: 300244's debt is well covered by operating cash flow (43.1%).
Interest Coverage: 300244's interest payments on its debt are not well covered by EBIT (2x coverage).